| BACHEM N -B- | 355.00 / -2.20% |
| Date/Time | 11/24 / 17:31 |
| Chg. / Chg.(%) | -8.00 / -2.20% |
| Bid | 353.00 / 85 |
| Ask | 355.00 / 52 |
| Open | 362.00 |
| Previous Close | 363.00 |
| High | 362.00 |
| Low | 353.50 |
| Volume [CHF] | 6,688,051.50 |
| Volume [Units] | 20,075 |
| Price fixings | 888 |
| ISIN | CH0012530207 |
| Security | BANB |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 355.00 |  |
20,075 |
| London Inter.. | 356.70 | |
593 |
| Lang & Schwa.. | 321.50 | |
|
| Nasdaq Other.. | 418.0000 | 48 | |
| Cboe Europe .. | 129.20 | 126 | |
| Cboe Europe .. | 128.80 | 58 | |
| Turquoise | 128.80 |  |
13 |
| Frankfurt | 115.0000 | 0 | |
| Berlin | 116.20 | 0 | |
| München | 114.80 | 0 | |
| Hamburg | 114.80 | 0 | |
| EUREX | Options | ||
News
- Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome
05/14/2020 / 07:00 - GlobeNewswire - Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
05/04/2020 / 14:30 - GlobeNewswire - Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Trial
04/28/2020 / 15:24 - GlobeNewswire - Vaccine Contract Manufacturing Market, 2030 - Market is Anticipated to Generate Revenues Worth USD 100 Billion by 2025
10/04/2019 / 10:05 - GlobeNewswire - Global Pharmaceutical Contract Manufacturing Market 2018-2025 - Patent Expiration Of Small Molecules Drugs & Advanced Technologies In API And FDF Manufacturing
03/26/2019 / 10:57 - GlobeNewswire
Real-time